Vaccine News and Research

Latest Vaccine News and Research

What is the link between influenza vaccination and the severity of COVID-19 infection?

Researchers performed a systematic review and meta-analysis to investigate whether influenza vaccinations could reduce COVID-19 severity outcomes.

25 Aug 2022

Study suggests inclusion of the Omicron BA.5 strain in a SARS-CoV-2 vaccine would be beneficial in protection against this widely circulating variant

Researchers explored neutralizing antibodies against SARS-CoV-2 Omicron BA.1, BA.2, and BA.5 lineage infected patients.

25 Aug 2022

Virtual screening and molecular dynamics explore potential repurposed drugs against monkeypox virus

A recent study investigated ‘targets’ in the poxvirus and identified the protein residues active in MPV, following which eight potential anti-viral drugs were proposed.

25 Aug 2022

COVID-19 vaccine not linked to increased risk of stroke

Newly compiled data evaluated by researchers in the Department of Neurology and the Smidt Heart Institute at Cedars-Sinai shows that COVID-19 vaccines do not raise stroke risk--but that severe COVID-19 infection does.

24 Aug 2022

Survey reveals clear differences among the NYC boroughs in COVID behaviors and attitudes

As the nation follows new CDC recommendations to relax COVID-19 restrictions, a new survey of 2,500 New Yorkers conducted by the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) revealed clear differences among the boroughs in vaccine and booster uptake, childhood vaccination, treatment when sick and general trust in the safety and effectiveness of the vaccine.

24 Aug 2022

Experimental, genetically attenuated malaria vaccine warrants further exploration

Findings from a preliminary human study of an experimental, genetically attenuated malaria parasite immunization show this vaccine warrants further exploration.

24 Aug 2022

Social media messaging strategies can help educate young adults about HPV vaccine interventions

Public health researchers from the University of California, Irvine identified several social media messaging strategies to educate young adults and their parents about evidence-based interventions around the human papillomaviruses (HPV).

24 Aug 2022

Pregnancy outcomes after COVID-19 vaccination and infection

In a new study, researchers assessed early pregnancy outcomes after COVID-19 vaccination and infection.

24 Aug 2022

Recent rise in STIs in the U.S. foreshadows the new monkeypox outbreak

The recent rise in sexually transmitted infections (STIs) in the United States foreshadowed the new monkeypox outbreak.

24 Aug 2022

Ian Frazer Centre for Children’s Immunotherapy Research aims to advance pediatric cancer care

Australia's first dedicated children's immunotherapy center will investigate treatments to not only increase the survival of kids with cancer, but to also improve their ongoing quality of life.

24 Aug 2022

The role of SARS-CoV-2-specific T cells induced by infection, vaccination, or their combination in disease protection

Researchers evaluated how SARS-CoV-2-specific-T lymphocytes induced by infection, vaccination, or both conferred protection against severe COVID-19.

24 Aug 2022

The incidence rates of adverse events of special interest in COVID-19 vaccinated and non-vaccinated persons

Researchers monitored the safety of the four diverse SARS-CoV-2 vaccines approved by the EMA and MHRA in 2020 to 2021.

24 Aug 2022

Absolute vaccine effectiveness for third and fourth doses of mRNA COVID-19 vaccine against Omicron

Researchers analyzed the efficacy of the SARS-CoV-2 fourth-dose vaccination relative to no vaccination towards the Omicron BA.1 variant.

24 Aug 2022

Updated guidelines on the Valneva SARS-CoV-2 vaccine

The WHO provides interim guidelines for the use of the Valneva vaccine.

23 Aug 2022

Unconventional T cells influence immune responses in the lymph nodes

Lymph nodes trigger very different immune responses – depending on which body tissue they are connected to. Special T cells are responsible for this newly discovered relation.

23 Aug 2022

Wyss Institute's DNA nanotechnology-driven SPEAR protein-detection technology licensed to Spear Bio

Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Spear Bio, Inc.announced that the Institute's DNA nanotechnology-driven ultrasensitive SPEAR protein-detection technology has been licensed to the newly formed Boston-based startup.

23 Aug 2022

Vaccine News and Research

Latest Vaccine News and Research

What is the link between influenza vaccination and the severity of COVID-19 infection?

Study suggests inclusion of the Omicron BA.5 strain in a SARS-CoV-2 vaccine would be beneficial in protection against this widely circulating variant

Virtual screening and molecular dynamics explore potential repurposed drugs against monkeypox virus

COVID-19 vaccine not linked to increased risk of stroke

Survey reveals clear differences among the NYC boroughs in COVID behaviors and attitudes

Experimental, genetically attenuated malaria vaccine warrants further exploration

Social media messaging strategies can help educate young adults about HPV vaccine interventions

Pregnancy outcomes after COVID-19 vaccination and infection

Recent rise in STIs in the U.S. foreshadows the new monkeypox outbreak

Ian Frazer Centre for Children’s Immunotherapy Research aims to advance pediatric cancer care

The role of SARS-CoV-2-specific T cells induced by infection, vaccination, or their combination in disease protection

The incidence rates of adverse events of special interest in COVID-19 vaccinated and non-vaccinated persons

Absolute vaccine effectiveness for third and fourth doses of mRNA COVID-19 vaccine against Omicron

Updated guidelines on the Valneva SARS-CoV-2 vaccine

Unconventional T cells influence immune responses in the lymph nodes

Wyss Institute's DNA nanotechnology-driven SPEAR protein-detection technology licensed to Spear Bio

Marburg outbreak in Ghana causes African countries to stay alert

Case report describes clinical manifestation of monkeypox, SARS-CoV-2, and HIV coinfection

Epistasis leads to the reduction in genetic barrier to COVID-19 neutralizing antibody escape

DNA origami as an alternative platform to display the RBD of SARS-CoV-2

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in